|
BAG4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.175100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.757200E-03 |
| Normal-vs-Stage2 |
6.441500E-03 |
| Normal-vs-Stage3 |
3.558800E-03 |
| Normal-vs-Stage4 |
8.579600E-03 |
| Stage1-vs-Stage2 |
5.120800E-01 |
| Stage1-vs-Stage3 |
5.477800E-01 |
| Stage1-vs-Stage4 |
6.412600E-01 |
| Stage2-vs-Stage3 |
8.453600E-01 |
| Stage2-vs-Stage4 |
8.644400E-01 |
| Stage3-vs-Stage4 |
9.943400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.259200E-03 |
| Normal-vs-AfricanAmerican |
3.115600E-01 |
| Normal-vs-Asian |
1.202070E-03 |
| Caucasian-vs-AfricanAmerican |
3.448600E-01 |
| Caucasian-vs-Asian |
2.625000E-01 |
| AfricanAmerican-vs-Asian |
1.139630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.564900E-03 |
| Normal-vs-Female |
3.315700E-03 |
| Male-vs-Female |
6.317600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.911700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.566500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.856800E-03 |
| Normal-vs-Age(81-100Yrs) |
8.048300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.828040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.149000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.354400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.488600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.162800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.204600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.884200E-01 |
| Classical-VS-Follicular |
5.620500E-03 |
| Classical-VS-Other |
1.449350E-01 |
| Classical-VS-Normal |
2.793800E-02 |
| Tall-VS-Follicular |
2.458200E-01 |
| Tall-VS-Other |
2.503800E-01 |
| Tall-VS-Normal |
4.693600E-02 |
| Follicular-VS-Other |
5.806800E-01 |
| Follicular-VS-Normal |
1.152890E-04 |
| Other-VS-Normal |
1.873730E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.104140E-03 |
| Normal-vs-N1 |
1.236250E-03 |
| N0-vs-N1 |
4.312400E-01 |
|
|
